fluoxetine has been researched along with ascorbic acid in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rasker, MC | 1 |
| Calixto, JB; Lin, J; Rodrigues, AL; Rosa, AO; Santos, AR | 1 |
| Dakhale, GN; Khanzode, SD; Khanzode, SS; Palasodkar, R; Saoji, A | 1 |
| Budni, J; Colla, A; de Freitas, AE; de Oliveira Balen, G; dos Santos, DB; Farina, M; Moretti, M; Severo Rodrigues, AL | 1 |
| Amr, M; El-Mogy, A; Lakhan, SE; Shams, T; Vieira, K | 1 |
| Almeida, IV; Düsman, E; Mantovani, MS; Mariucci, RG; Vicentini, VE | 1 |
| Corbett, AM; Flannery, T; Lizzi, J; Sanghvi, S; Sibbit, B; Sieber, S; Wyatt, N | 1 |
| Choi, HY; Lee, JY; Yune, TY | 1 |
| Abushamma, A; Corbett, AM; Gagle, S; Johnson, A; Nagarajan, D; Sharma, N; Sulehria, T | 1 |
| Ali, G; Alkahramaan, YMSA; Arif, M; Gohar, A; Khan, MS; Rashid, U; Rauf, K; Sewell, RDE | 1 |
1 review(s) available for fluoxetine and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for fluoxetine and ascorbic acid
| Article | Year |
|---|---|
Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors.
Topics: Adult; Antioxidants; Ascorbic Acid; Citalopram; Depression; Female; Fluoxetine; Humans; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Superoxide Dismutase; Time Factors | 2003 |
Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study.
Topics: Adjuvants, Pharmaceutic; Antidepressive Agents; Ascorbic Acid; Child; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Pilot Projects | 2013 |
12 other study(ies) available for fluoxetine and ascorbic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
[Risk of hemorrhage with administration of fluoxetine (Prozac) or fluvoxamine (Fevarin)].
Topics: Ascorbic Acid; Ecchymosis; Female; Fluoxetine; Fluvoxamine; Humans | 1993 |
Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice.
Topics: Animals; Antidepressive Agents; Arginine; Ascorbic Acid; Behavior, Animal; Chlorides; Depression; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Fluoxetine; Free Radical Scavengers; Guanosine Monophosphate; Hindlimb Suspension; Imipramine; Immobilization; Ketamine; Male; Mice; Motor Activity; Nitric Oxide; Nitric Oxide Donors; Pain Measurement; Receptors, N-Methyl-D-Aspartate; S-Nitroso-N-Acetylpenicillamine; Swimming; Time Factors; Zinc Compounds | 2003 |
Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress.
Topics: Animals; Antidepressive Agents; Antioxidants; Ascorbic Acid; Catalase; Cerebral Cortex; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Glutathione; Glutathione Reductase; Hippocampus; Lipid Peroxidation; Mice; Motor Activity; Oxidative Stress; Stress, Psychological; Treatment Outcome | 2012 |
Cytotoxicity and mutagenicity of fluoxetine hydrochloride (Prozac), with or without vitamins A and C, in plant and animal model systems.
Topics: Animals; Ascorbic Acid; Cell Division; Drug Combinations; Fluoxetine; Humans; Mutagenicity Tests; Mutagens; Onions; Rats; Vitamin A | 2014 |
Increasing neurogenesis with fluoxetine, simvastatin and ascorbic Acid leads to functional recovery in ischemic stroke.
Topics: Animals; Ascorbic Acid; Brain; Brain Ischemia; Drug Therapy, Combination; Female; Fluoxetine; Male; Neurogenesis; Rats; Rats, Long-Evans; Rats, Wistar; Recovery of Function; Simvastatin; Stroke | 2015 |
Fluoxetine and vitamin C synergistically inhibits blood-spinal cord barrier disruption and improves functional recovery after spinal cord injury.
Topics: Animals; Antioxidants; Ascorbic Acid; Blood-Brain Barrier; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Recovery of Function; Selective Serotonin Reuptake Inhibitors; Spinal Cord; Spinal Cord Injuries | 2016 |
Increasing Progenitor Cell Proliferation in the Sub-Ventricular Zone: A Therapeutic Treatment for Progressive Multiple Sclerosis?
Topics: Animals; Ascorbic Acid; Cell Proliferation; Drug Therapy, Combination; Female; Fluoxetine; Lateral Ventricles; Male; Multiple Sclerosis, Chronic Progressive; Neural Stem Cells; Neurogenesis; Rats, Sprague-Dawley; Sex Factors; Simvastatin | 2020 |
Effect of Gabapentin-Fluoxetine Derivative GBP1F in a Murine Model of Depression, Anxiety and Cognition.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Ascorbic Acid; Behavior, Animal; Cognition; Depression; Disease Models, Animal; Dopamine; Fluoxetine; Gabapentin; Hydroxyindoleacetic Acid; Mice; Serotonin | 2023 |